AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sugatab-M 1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Delight Biopharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Sugatab-M 1 Tablet PR

DiabetaComb-1, a dual-action antidiabetic medication, manages type 2 diabetes in adults. This combination therapy effectively regulates blood glucose. DiabetaComb-1 should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, potentially causing kidney complications, vision loss, neuropathy, and limb damage. DiabetaComb-1 is only one element of a comprehensive diabetes management plan encompassing diet, exercise, and weight control as directed by your doctor. Lifestyle adjustments are key to successful diabetes control. Hypoglycemia (low blood sugar) is a common side effect, manifested by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic potential. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. DiabetaComb-1 is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should consult their physician before initiating treatment. Pregnant or breastfeeding women require medical consultation prior to use. Regular blood glucose monitoring, along with blood cell and liver function tests as advised, is necessary.

Uses of Sugatab-M 1 Tablet PR

Managing type 2 diabetes

Major Benefits of Sugatab-M 1 Tablet PR:

Follow your physician's instructions or consult the product label for proper administration. Consume one Sugatab-M tablet (PR) with a meal.

Common Side effects of Sugatab-M 1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Sugatab-M 1 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidance. Administer one Sugatab-M tablet (PR) with a meal.

How Sugatab-M 1 Tablet PR works:

Sugatab-M PR, a single-dose tablet, combines glimepiride and metformin to manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sugatab-M 1 Tablet PR and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sugatab-M 1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Sugatab-M 1 Tablet PR are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Sugatab-M 1 Tablet PR cautiously, potentially requiring dosage modification. Physician consultation is recommended. Sugatab-M 1 Tablet PR is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Sugatab-M 1 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician before use. A reduced initial dose is typically recommended for those with mild to moderate liver disease; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Sugatab-M 1 Tablet PR :

Should you forget a Sugatab-M 1 Tablet PR dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sugatab-M 1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sugatab-M 1 Tablet PR

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sugatab-M 1 Tablet PR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sugatab-M 1 Tablet PR and seek immediate medical attention.
Sugatab-M 1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's not suitable for type 1 DM.
Sugatab-M 1 Tablet PR may cause common side effects including low blood sugar, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Sugatab-M 1 Tablet PR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some researchers.
Sugatab-M 1 Tablet PR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Sugatab-M 1 Tablet PR with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Sugatab-M 1 Tablet PR
62
MRP 75
17% off